A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.
Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB; American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments.
Sanacora G, et al. Among authors: summergrad p.
JAMA Psychiatry. 2017 Apr 1;74(4):399-405. doi: 10.1001/jamapsychiatry.2017.0080.
JAMA Psychiatry. 2017.
PMID: 28249076
Review.